Sign in

CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(919) 636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,310,718
in 4 filings, $1.2M under 10b5-1 plans

Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Andrade Robert −$884K CHIEF FINANCIAL OFFICER sold 26% of stake
  2. Brughera Marco Maria −$160K Director sold 100% of stake
  3. Sayad Pierre Sargis −$146K Chief Medical Officer sold 56% of stake
  4. Raykov Rosty −$121K Former Director sold 7% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-31 Cioffi Christiana Marie Chief Strategy Officer Grant or award +156 28,902
2026-10-31 Sayad Pierre Sargis Chief Medical Officer Grant or award +168 13,701
2026-10-31 Evans Terry L Chief Commercial Officer Grant or award +168 24,181
2026-10-31 Hackman Jeffrey S. Chief Executive Officer Grant or award +1,159 70,844
2026-10-31 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +1,703 248,558
2026-10-12 Cioffi Christiana Marie Chief Strategy Officer Grant or award +3,946 $5.53 $22K 28,746
2026-10-12 Sayad Pierre Sargis Chief Medical Officer Grant or award +3,846 $5.53 $21K 13,533
2026-10-12 Evans Terry L Chief Commercial Officer Grant or award +2,326 $5.53 $13K 24,013
2026-10-12 Hackman Jeffrey S. Chief Executive Officer Grant or award +2,224 $5.53 $12K 69,685
2026-10-12 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +3,846 $5.53 $21K 246,855
2026-09-30 Cioffi Christiana Marie Chief Strategy Officer Grant or award +156 24,800
2026-09-30 Sayad Pierre Sargis Chief Medical Officer Grant or award +168 9,687
2026-09-30 Evans Terry L Chief Commercial Officer Grant or award +168 21,687
2026-09-30 Hackman Jeffrey S. Chief Executive Officer Grant or award +1,159 67,461
2026-09-30 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +1,703 243,009
2026-09-15 Brughera Marco Maria Director Option exercise 10b5-1 +15,545 $2.11 $33K 15,545
2026-09-15 Brughera Marco Maria Director Sale 10b5-1 −15,545 $10.29 $160K 0
2026-09-15 Brughera Marco Maria Director Option exercise · Stock Option 10b5-1 −15,545 220,000
2026-09-01 Raykov Rosty Former Director Sale 10b5-1 −10,000 $12.11 $121K 124,411
2026-08-31 Raykov Rosty Former Director Grant or award 10b5-1 +2,778 134,411

Page 1 of 8 · 159 trades